Please see link below. The article is a bit long and you would have to read the whole article to get the full story but studies suggested that tamoxifen improved the response of metastatic melanoma to combination chemotherapy including carmustine, cisplatin, and dacarbazine.
The effect of tamoxifen on melanoma cells is not clearly understood. Whether some melanoma cells do express ER (23,24) or whether estrogen binding to tyrosine hydroxylase (25) explains the estrogen binding data with melanoma cell cytosol has not
been resolved. But, regardless of the mechanism of action, there are data from a randomized therapeutic trial that tamoxifen may augment the response of melanoma to single-agent dacarbazine. It is not unreasonable to ask whether dacarbazine and tamoxifen are comparable in efficacy to potentially more toxic chemotherapy
regimens with drugs such as cisplatin. There is now both the preclinical and the clinical trial rationale to support the conduct of such a trial.
- Tamoxifen Information for Consumers
- Tamoxifen Information for Healthcare Professionals (includes dosage details)
- Side Effects of Tamoxifen (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 31 Dec 2011 • 3 answers
Posted 7 Dec 2012 • 1 answer
Posted 21 Oct 2015 • 0 answers
Posted 9 Jun 2016 • 0 answers
Posted 19 days ago • 0 answers